Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

Consortium aims to speed the development and delivery of customized or ‘bespoke’ gene therapies WASHINGTON, May 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate gene therapy resources that the research community can use to streamline gene... Read more

GE Healthcare enters homecare segment with strategic investment in Pulsenmore, aims to increase peace of mind for expectant mothers and reduce in-person visits

BOSTON – May 12, 2022 – GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health.  This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions and will also support their goal to pursue U.S. FDA... Read more